Диссертация (1174373), страница 18
Текст из файла (страница 18)
Moshita, J. Blaustein // J. Americ. Geriatric. Society. – 1994. – Vol. 42. – P. 1094–1099.187. Stratton I. Association of systolic blood pressure with macro vascular andmicrovascular complications of type 2 diabetes (UKPDS 36): prospective observationalstudy // BMJ. - 2000. - № 321. - P. 405-412.188. Szabo, C.
Pathogenetic role of peroxynitrite in the development of diabetesand diabetic vascular complications: studies with FP15, a novel potent peroxynitritedecomposition catalyst / C. Szabo et al. // Mol Med. 2002. - Vol.8. - P. 571-580.189. Tinetti M. Identifying mobility dysfunctions in eldery patients // JAMA. –1988.
– Vol. 259. – P. 1058.190. Tinetti M. Perfomance oriented assessment of mobility problems in elderypatients // J. Americ. Geriatric. Society. – 1986. – № 34. – P. 119–126.191. Weber, P. Type 1 diabetes and LADA-occurrence of HLA-DRB1 *03 andDRB1 *04 alleles in two age different groups of diabetics / P. Weber, H. Meluzínová,104H.Kubesová,P.Ambrosová, V.Polcarová, P.Cejkova,M. Cerna//Adv.Gerontol.
2010; 23 (2):243-8.192. Weitz, J.I. Diagnosis and treatment of chronic arterial insufficiency of thelower extremities: a critical review // Circulation. -1996. -Vol. 94. - P. 326-349.193. Vin, A. Diabetic neuropathies // Diabetologia. – 2000. - Vol. 43. - P. 957973..